In January last year, the National Institutes of Health issued a new requirement for grant funding in basic science: Researchers must discuss how gender as a biological variable will impact their research.
Teresa Woodruff, director of the Women’s Health Research Institute at Northwestern University, told Drug Delivery Business News that this helped support their effort to develop a model that could eventually serve as a way for pharmaceutical companies to consider female biology when developing drugs.
Woodruff, researchers at the University of Illinois at Chicago and Draper Laboratory worked collaboratively on an NIH-funded project to make a 3D model of the female 28-day menstrual cycle using human tissue. The team’s work was published today in Nature Communications.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!